Well Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN)

Post Date

March 15th 2013

Application Due Date

April 30th 2013

Funding Opportunity Number

CDC-RFA-DP13-1302

CFDA Number(s)

93.094

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Health

Number of Awards

21

Eligibility Categories

Other

Eligibility Information 1. Eligible Applicants: ╔ State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) . ╔ American Indian/Alaska Native tribal governments (federally recognized or state-recognized) ╔ American Indian/Alaska native tribally designated organizations 2. Special Eligibility Requirements: Applicants must be recipients of the NBCCEDP program funding. Eligibility is limited by Congressional statute. WISEWOMAN is authorized under the National Breast and Cervical Cancer Early Detection Program to expand screening services inclusive of cardiovascular risks. The WISEWOMAN Program participants must be enrolled in the NBCCEDP to be eligible for WISEWOMAN services; therefore, only organizations who are currently receiving NBCCEDP awards are eligible.

Funding

• Estimated Total Funding:

  $64000000

• Award Range:

  $500000 - $2000000

Grant Description

The purposes of the WISEWOMAN program are: 1) assuring that cardiovascular screening is provided to women ages 40-64 who are participants in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP); 2) working with community-based organizations to provide evidence-based prevention services to those women in need of them (through agreements with organizations such as the YMCA, Weight Watchers, and those that provide Diabetes Primary Prevention Programs); 3) improving the management and control of hypertension by integrating innovative health system-based approaches and strengthening community-clinical linkages (such as team-based care and pharmacy medication management programs); and 4) gathering and reporting program related evaluation data, including impact measures.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC
  Procurement and Grants Office
  TIMS
  Phone 770-488-2700

• Agency Mailing Address:

  PGO Technical Information Management Section

• Agency Email Address:

  PGOTIM@cdc.gov

• More Information:

  THIS IS NOT AN ACTIVE LINK. PLEASE CLICK ON THE WORDS "FULL ANNOUNCEMENT" AT THE TOP OF THIS PAGE